P53 peptide vaccine
US8663646B2 · kind B2 · utility
0Cited by
0References
5Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Dec 3, 2009 |
| Grant date | Mar 4, 2014 |
| Priority date | — |
| Expiry date | Jun 13, 2030 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K14/4746
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention relates to a peptide derived from p53 that could be used as a vaccine against cancer.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.